Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEFLUX study of parnaparin for superficial venous thrombosis
2005-005957-23Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of parnaparin in Superficial Phlebitis (3 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Primary composite endpoint at 30 days. Started Mar 2006; status: completed.
02
Drugs
parnaparin
03
Conditions
Superficial Phlebitis
Beyond the preview
Go deeper on 2005-005957-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005957-23.